Cite
HARVARD Citation
Masters, J. et al. (2021). Pharmacokinetics and Safety of Glasdegib in Participants With Moderate/Severe Hepatic Impairment: A Phase I, Single‐Dose, Matched Case‐Control Study. Clinical pharmacology in drug development. 10 (7), pp. 707-717. [Online].